Chemed Corp
NYSE:CHE

Watchlist Manager
Chemed Corp Logo
Chemed Corp
NYSE:CHE
Watchlist
Price: 550.63 USD 0.7% Market Closed
Market Cap: 8B USD

Chemed Corp
Investor Relations

Chemed Corporation, a somewhat enigmatic yet resolutely steadfast entity, operates in the realms of hospice care and plumbing services, a duality that intrigues analysts and investors alike. Established through strategic foresight, Chemed has crafted a remarkably resilient business model by housing two distinct subsidiaries under its corporate umbrella: VITAS Healthcare and Roto-Rooter. VITAS Healthcare, which still stands as the nation's largest provider of end-of-life care, dominates the hospice sector by offering comprehensive palliative care services right at the patients' doorstep, aiming to ensure dignity and comfort during life's final stages. This subsidiary capitalizes on a combination of Medicare and Medicaid reimbursements as well as private insurances, which form the backbone of its revenue stream.

Meanwhile, Roto-Rooter, a company with a name synonymous with plumbing repair and maintenance, fortifies Chemed's revenue streams through an entirely different channel. Known as a household name across America, Roto-Rooter offers an extensive range of services from emergency plumbing repair to water cleanup and restoration. With its franchise model combined with company-operated branches, Roto-Rooter generates income primarily through service fees. The dual nature of Chemed’s operational style—a blend of healthcare sensitivity and industrial pragmatism—not only ensures diversified income avenues but also exemplifies a pragmatic approach to risk management. This business strategy, deftly combining distinct yet robust sectors, allows Chemed to weather economic fluctuations that might impact one industry but not the other, ultimately creating a stable financial foundation for the company.

Show more
Loading

Earnings Calls

2024 Q4
Feb 10, 2025
Show Transcript
Previous
Next
Strong performance with wealth management, stable guidance, and ongoing capital returns.
2024 Q4
Feb 10, 2025

In the latest earnings call, the company's wealth management division highlighted a net new money inflow of $21 billion, indicating robust demand despite a seasonal Q4 drop of 15%. Management projects slight increases in net interest income (NII) tied to interest rate shifts, predicting an annual impact of between $50 million to $100 million. The return on equity (ROE) target of 15% to 17% remains, bolstered by expected stable market conditions. Additionally, $5 billion in capital returns are planned, maintaining investor confidence in growth while managing risks effectively.

Show Full Analysis

Management

Mr. Kevin J. McNamara
CEO, President & Director
No Bio Available
Mr. Spencer S. Lee
Executive Vice President
No Bio Available
Mr. Thomas C. Hutton J.D.
VP & Director
No Bio Available
Ms. Lisa A. Reinhard
VP, Chief Administrative Officer & Secretary
No Bio Available
Ms. Sherri Warner
Director of Investor Relations
No Bio Available
Mr. Nathan J. McNamara
VP & Chief Strategy Officer
No Bio Available

Contacts

Address
OHIO
Cincinnati
255 E 5th St Ste 2600
Contacts
+15137626690.0
www.chemed.com